StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Friday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 5.0 % BTX opened at $1.67 on Friday. The stock’s fifty day moving average is $1.81 and its two-hundred day moving average is […]